T, C., A, W., MCB, G., Jr, W. W., CH, L., HY, L., . . . B, S. (2021). Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancer. Nature communications, 12(1), 5045. https://doi.org/10.1038/s41467-021-25188-0
Chicago Style (17th ed.) CitationT, Cascone, et al. "Nodal Immune Flare Mimics Nodal Disease Progression Following Neoadjuvant Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer." Nature Communications 12, no. 1 (2021): 5045. https://doi.org/10.1038/s41467-021-25188-0.
MLA (9th ed.) CitationT, Cascone, et al. "Nodal Immune Flare Mimics Nodal Disease Progression Following Neoadjuvant Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer." Nature Communications, vol. 12, no. 1, 2021, p. 5045, https://doi.org/10.1038/s41467-021-25188-0.